All articles tagged: Major depressive disorder, recurrent, moderate (F33.1)
Evalytics
08 April at 08.43 PM
FDA Clears Rejoyn: A New Era for App-Based Depression TreatmentThe FDA approved Rejoyn, an app for treating major depressive disorder, as a complementary therapy to antidepressants. Developed by Otsuka America and Click Therapeutics, Rejoyn offers emotional training exercises and interactive messaging alongside traditional treatments. |
HealthDay
03 January at 03.52 PM
Sequential Bilateral Neurostimulation Aids Treatment-Resistant DepressionA novel sequential bilateral neurostimulation protocol has the potential to improve treatment-resistant major depressive disorder (TR-MDD), according to a letter published in the November issue of Brain Stimulation.Sabrina K. Segal, Ph.D., from the Family Care Center in Lone Tree, Colorado, and colleagues conducted a naturalistic |
|
Evalytics
22 December at 04.22 PM
Psychedelic psilocybin-assisted therapy found to reduce depressive symptoms in adults with cancer and depressionA study shows that psilocybin-assisted therapy can effectively reduce depressive symptoms, offering promise as a treatment for major depressive disorder. |
|
HealthDay
19 December at 04.43 PM
Psilocybin Effective for Reducing Depression in Patients With CancerFor patients with cancer and major depressive disorder, psilocybin is effective for reducing depression severity and is acceptable from the patient perspective, according to two studies published online Dec. 18 in Cancer.Manish Agrawal, M.D., from Sunstone Therapies in Rockville, Maryland, and colleagues examined the safety, feasibilit |
|
HealthDay
04 December at 04.51 PM
Pupillary Light Reflex Can Predict Improvement With rTMS in DepressionFor patients with major depressive disorder (MDD), pretreatment pupillary light reflex (PLR) could predict clinical improvement with repetitive transcranial magnetic stimulation (rTMS) treatment, and improvement in depression is better for those receiving intermittent theta burst stimulation (iTBS), according to one study published online Oct. 15 in the |
|
HealthDay
01 December at 11.09 PM
Metabolic Biomarkers May Aid Mood Disorder DiagnosisMetabolomic profiling may improve the differential diagnosis of mood disorders, according to a proof-of-concept study published online Oct. 25 in JAMA Psychiatry.Jakub Tomasik, Ph.D., from the University of Cambridge in the United Kingdom, and colleagues examined metabolomic biomarker signatures from dried blood spots among patients |
MedScape
28 November at 01.50 AM
Sleep-Disordered Breathing Common After StrokeSleep-disordered breathing remains common after stroke, affecting 60% of patients and showing no decline in prevalence from 2010 to 2023, a new meta-analysis suggested. |
Medpage Today
24 November at 08.00 PM
IDH Inhibitor Activity in Brain Cancer Persists With Longer Follow-UpHOUSTON -- Progression-free survival (PFS) in IDH-mutant low-grade glioma remained twice as high in adults who received vorasidenib (Voranigo) after surgery versus placebo, according to a follow-up analysis of a pivotal clinical... |
Medical xPress
23 November at 01.50 PM
RNA editing is the next frontier in gene therapy—here's what you need to knowThe United States Food and Drug Administration has just approved the first-ever clinical trial that uses CRISPR-Cas13 RNA editing. Its aim is to treat an eye disease called wet age-related macular degeneration that causes vision loss in millions of older people worldwide. |
|
HealthDay
22 November at 04.44 PM
Semaglutide, Liraglutide May Reduce Hospitalization Risk for Alcohol Use DisorderSemaglutide and liraglutide are associated with a reduced risk for hospitalization due to alcohol use disorder (AUD), according to a study published online Nov. 13 in JAMA Psychiatry.Markku Lähteenvuo, M.D., Ph.D., from the University of Eastern Finland in Kuopio, and colleagues conducted an observational study in Sweden using data from |
|
Medpage Today
17 November at 10.31 PM
Two Treatments That Don't Work for OsteoarthritisWASHINGTON -- If you're looking for nonsurgical osteoarthritis (OA) treatments with fewer side effects than ordinary pain relievers, two randomized trials presented here with negative results should at least narrow your search... |
|
MedScape
11 November at 07.56 AM
Scoring System Could Mean Better Access to Lung TransplantScoring system could improve access for hard-to-match candidates due to height and blood type. |
|
|
Medical xPress
07 November at 07.50 AM
How key results could influence health policyThe results of some congressional races may foreshadow who will have outsize health policy influence in Congress next year. |
|
Medpage Today
05 November at 07.00 PM
Mpox Cases in Congo May Be StabilizingGOMA, Congo -- Some health officials say mpox cases in Congo appear to be "stabilizing" -- a possible sign that the main epidemic for which the World Health Organization (WHO) made a global emergency declaration in August... |
|
Medical xPress
02 November at 07.40 AM
Insulin resistance caused by sympathetic nervous system over-activation, a paradigm-shifting study findsRutgers Robert Wood Johnson Medical School and collaborating institutions have found that overnutrition leads to insulin resistance and metabolic disorders through increased activity of the sympathetic nervous system (SNS). The study shows that reducing SNS activity can prevent insulin resistance induced by a high-fat diet, suggesting a new understanding of how obesity causes insulin resistance. |
|
MedScape
31 October at 06.30 AM
Report: Rethink Race-Based Adjustments in Clinical ToolsThe slow adoption of race-neutral tools may harm patient care outcomes, according to a new report from the National Academies of Sciences, Engineering, and Medicine. |
Newsletter for Healtcare
Join over 1.2M subscribers and receive one weekly email.
